Final Report - Select Investigative Panel - Fetal Tissue Related

quote:

---

David Daleiden, an investigative journalist, released undercover videos beginning in July 2015, recorded while posing as the head of a company interested in the fetal tissue procurement business.

---

quote:

---

Multiple clips show abortion providers and executives admitting that their fetal tissue procurement agreements are profitable for clinics and help keep their bottom line healthy.

---

quote:

---

Planned Parenthood Federation of America (PPFA) also revealed that they intentionally had not set a policy about “remuneration” for fetal tissue because “the headlines would be a disaster.” While the organization’s executives told affiliates to “think, ‘New York Times headline’” if this went badly, at the end of the day, they thought “[selling fetal tissue] is a good idea.”

---

quote:

---

The Panel referred DVB’s potential violations of the California Revenue and Tax Code to the Orange County District Attorney. The Panel referred DVB’s potential violation of Title U.S.C. § 289g-2 to the United States Department of Justice

---

quote:

---

Conclusion In over 100 years of unrestricted research, fetal tissue has not proven to be useful for treating human disease. In contrast, although stem and progenitor cells from non-fetal tissues have only recently been discovered, they have rapidly yielded clinical treatments with proven benefit to patients. The alarmist claims that restrictions on human fetal tissue research would somehow delay or prevent the development of cures are entirely unfounded.

---

quote:

---

1) The Panel learned that StemExpress and certain abortion clinics may have violated the HIPAA privacy rights of vulnerable women for the sole purpose of increasing the harvesting of fetal tissue to make money. Referred to the U.S. Department of Health and Human Services.

2) The Panel uncovered evidence showing that StemExpress may have violated federal regulations governing Institutional Review Boards (IRBs). Referred to the U.S. Department of Health and Human Services.

3) The Panel discovered that the University of New Mexico may have been violating its state’s Anatomical Gift Act by receiving tissue from a late-term abortion clinic (Southwestern Women’s Options). Referred to the Attorney General of New Mexico.

4 & 5) The Panel conducted a forensic accounting analysis of StemExpress’ limited production
and determined that it may have been profiting from the sale of baby body parts. Referral sent to
El Dorado, California District Attorney, and the U.S. Department of Justice

....

7) The Panel discovered that DV Biologics, another tissue procurement company, may have been
profiting from the sale of fetal tissue, and was not collecting California sales tax from purchasers
of the baby body parts. The Orange County District Attorney has filed a lawsuit and the Panel
sent a supplemental referral.

---

quote:

---

10) The Panel learned that Planned Parenthood Gulf Coast may have violated both Texas law and U.S. law when it sold fetal tissue to the University of Texas. Referred to the Texas Attorney General.

---

quote:

---

The allegations include eyewitness accounts of the doctor killing infants who show signs of life both when partially outside the birth canal, in violation of the PartialBirth Abortion Ban Act, and after they are completely outside the birth canal, in violation of the Born-Alive Infants Protection Act and Texas murder statutes. Referred to the Texas Attorney General, and the U.S. Department of Justice.

---